Healthcare · Drug Manufacturers Specialty Generic · NYSE
Dr. Reddy's Laboratories Limited (RDY) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $10.18B, a trailing price-to-earnings ratio of 17.0 and a free-cash-flow yield of 1.9%. Over the most recent reported fiscal year, revenue grew 3.2% and free cash flow per share grew 52.5%.